Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ellis

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
BMC Cancer|December 5, 2014
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancerGordon C Wishart, Emad Rakha, Andrew Green, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphismDavid Harding, Paul B Baines, David Brull, et al.
Journal of Geriatric Oncology|May 22, 2018
Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohortHugo Schuil, Marloes Derks, Gerrit-Jan Liefers, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
American Journal of Clinical Pathology|December 20, 2008
External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
Scientific Reports|November 30, 2023
Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathwaysBehnaz Saidy, Richa Vasan, Rosie Durant, et al.
Molecular Diagnosis & Therapy|October 28, 2017
Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer PatientsHenry Okuchukwu Ebili, Victoria O Iyawe, Kikelomo Rachel Adeleke, et al.
Histopathology|December 16, 2020
Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breastRaluca Mihai, Grace Callagy, Omar L Qassid, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
BMC Cancer|December 5, 2014
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancerGordon C Wishart, Emad Rakha, Andrew Green, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2002
Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphismDavid Harding, Paul B Baines, David Brull, et al.
Journal of Geriatric Oncology|May 22, 2018
Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohortHugo Schuil, Marloes Derks, Gerrit-Jan Liefers, et al.
Histopathology|June 13, 2024
Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation studyAyat G Lashen, Michael Toss, Islam Miligy, et al.
American Journal of Clinical Pathology|December 20, 2008
External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance schemeJohn M S Bartlett, Merdol Ibrahim, Bharat Jasani, et al.
Scientific Reports|November 30, 2023
Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathwaysBehnaz Saidy, Richa Vasan, Rosie Durant, et al.
Molecular Diagnosis & Therapy|October 28, 2017
Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer PatientsHenry Okuchukwu Ebili, Victoria O Iyawe, Kikelomo Rachel Adeleke, et al.
Histopathology|December 16, 2020
Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breastRaluca Mihai, Grace Callagy, Omar L Qassid, et al.
Health Technology Assessment (Winchester, England)|November 3, 2020
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCTStephen Duffy, Daniel Vulkan, Howard Cuckle, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Pageof 10